Becton, Dickinson and Co. | BDX - Capital Ordinaire





Capital Ordinaire Changement Date
Abbott USD 1.74B 2.94M 2026-03
Agilent USD 281.97M 252K 2026-06
Align Technology USD 71.04M 578K 2026-09
AngioDynamics USD 41.57M 127K 2025-09
Baxter International USD 517M 549K 2026-06
Becton, Dickinson and Co. USD 272.39M 98.21M 2026-09
Bio-Rad Laboratories USD 26.74M 91K 2026-06
Boston Scientific USD 1.48B 2.66M 2025-12
Cooper Companies USD 190.1M 5.01M 2026-06
Danaher USD 703.4M 500K 2026-09
Dentsply International USD 198.2M 1000K 2026-09
Dexcom USD 377.4M 8.5M 2026-06
Edwards Lifesciences USD 576.6M 400K 2026-06
Globus Medical USD 132.66M 1.59M 2026-09
Insulet USD 69.37M 16K 2026-09
Integra LifeSciences USD 77.78M 39K 2026-06
Intuitive Surgical USD 353.28M 885K 2026-09
J&J USD 2.41B 1.64M 2026-06
Medtronic USD 1.28B 130K 2026-06
Solventum Corp USD 169.96M 156.65K 2026-09
Stryker USD 383.4M 416K 2026-06
Tandem Diabetes Care USD 69.76M 217K 2026-09
Teleflex USD 42.37M 1.89M 2026-06
Terumo JPY 1.48B 131K 2026-09
Thermo Fisher Scientific USD 369.75M 1.88M 2026-09
Zimmer Biomet Holdings USD 190.1M 3.3M 2026-09